Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Syndromology is Scopus-indexed (Q4, CiteScore 1.9), WoS SCIE. Published by S. Karger AG.
Checked against the index lists dated .
ISSN 1661-8769Verify ISSN ↗1661-8777Verify ISSN ↗
Publisher: S. Karger AG
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Genetics (clinical) | 78 / 100 | 22nd | Q4 |
| Genetics | 299 / 357 | 16th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2010–present, best quartile Q4, CiteScore 1.9.
Molecular Syndromology is Q4 in Genetics (clinical) (rank 78 of 100) and Q4 in Genetics (rank 299 of 357), by CiteScore 2025.
Molecular Syndromology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.9, which places it in quartile Q4 at the 22nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.420, quartile Q3, with an H-index of 47.
Molecular Syndromology is published by S. Karger AG. Its print ISSN is 1661-8769 and its online ISSN is 1661-8777.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Molecular Syndromology has an h-index of 54 and a 2-year mean of 0.63 citations per paper (OpenAlex). Its Scopus CiteScore is 1.9, quartile Q4. On 2-year citations it ranks #82 of 99 Scopus journals in Genetics (clinical).
Molecular Syndromology published 91 papers in 2025; its busiest recent year was 2024 with 104. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 93 research articles (2025–2026), authors are most often from Türkiye (63.1%), Brazil (3.8%) and Netherlands (3.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.